Nvidia H200 Approved for China Sales; 10 Buyers Cleared, Lifting Semiconductor Capex

In a significant reversal of prior export-control restrictions, the US government authorized Nvidia to sell its H200 chips to 10 Chinese buyers, effective May 14. This approval marks a pragmatic shift in the Trump administration's approach to tech trade with China: rather than blanket restrictions, there is now a path for selective, monitored sales that balance national security concerns with the economic imperative of unlocking critical semiconductor revenue for US chip manufacturers.

The H200 is Nvidia's latest-generation inference processor, designed for long-context AI workloads and high-throughput model serving. Chinese cloud providers and AI infrastructure companies have been starved of cutting-edge Nvidia silicon for over 18 months due to export controls, forcing them to develop domestic alternatives (like Huawei's Ascend chips) or downgrade to older, less powerful processors. The approval of H200 sales to 10 specific entities suggests a tailored approach: the government can vet individual customers and monitor shipments rather than imposing across-the-board bans.

For Nvidia, this is a potential multi-billion-dollar revenue unlock. China represents a significant portion of global AI infrastructure capex, and Nvidia has been ceding market share to homegrown competitors in the interim. Jensen Huang's presence at the Beijing summit reinforces that the company is positioning itself as a beneficiary of US-China trade normalization. Markets have priced Nvidia's market cap near $5.5 trillion on the strength of generative AI adoption; this H200 approval removes a major downside tail risk (the risk of permanent China market exclusion) and opens upside if the company can ramp H200 shipments.

However, a countervailing risk exists: Chinese competitors are improving rapidly, and a one-time approval does not guarantee long-term market access if political dynamics shift. Additionally, some of Nvidia's existing China revenue (via grey markets and reexports) is likely already baked into current valuations, so the approval may represent less incremental upside than headline optimism suggests.